Protalix BioTherapeutics
PLX
#8917
Rank
โ‚น12.72 B
Marketcap
โ‚น158.20
Share price
-2.79%
Change (1 day)
6.60%
Change (1 year)

Earnings for Protalix BioTherapeutics (PLX)

Earnings in 2025 (TTM): โ‚น0.64 Billion

According to Protalix BioTherapeutics 's latest financial reports the company's current earnings are โ‚น61.84 Million. In 2024 the company made an earning of โ‚น0.47 Billion a decrease over its 2023 earnings that were of โ‚น1.06 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Protalix BioTherapeutics from 1999 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚น0.64 B36.72%
2024 โ‚น0.47 B-55.62%
2023 โ‚น1.06 B-199.05%
2022 -โ‚น1.08 Billion-40.38%
2021 -โ‚น1.81 Billion-732.31%
2020 โ‚น0.28 B-130.53%
2019 -โ‚น0.94 Billion189.85%
2018 -โ‚น0.33 Billion-95.29%
2017 -โ‚น6.87 Billion308.12%
2016 -โ‚น1.69 Billion-32.37%
2015 -โ‚น2.49 Billion10.11%
2014 -โ‚น2.27 Billion-7.59%
2013 -โ‚น2.45 Billion
2011 -โ‚น2.84 Billion-19.39%
2010 -โ‚น3.52 Billion20.87%
2009 -โ‚น2.91 Billion32.26%
2008 -โ‚น2.2 Billion-5.46%
2007 -โ‚น2.33 Billion
2004 -โ‚น15.06 Million12.35%
2003 -โ‚น13.4 Million-11.1%
2002 -โ‚น15.08 Million-57.03%
2001 -โ‚น35.08 Million1.03%
2000 -โ‚น34.72 Million-53.22%
1999 -โ‚น74.21 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amicus Therapeutics
FOLD
โ‚น0.45 B-33.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚น53.02 B 7,718.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น1.077 T 158,795.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น161.10 B 23,656.54%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel